http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2198766-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_84d9adaa7e7ce01ce8020f5c721aba10 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H1-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07H17-08 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H17-08 |
| filingDate | 1998-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2004-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25c502562d152c8f2f4ac8c7759d623d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_16ba33bc9cbd0418b26672496f6911ad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff53775be1f0989e7c418f7cfb8e7a43 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_753762b254eb0e4d7ab5c5df5648db1e |
| publicationDate | 2004-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2198766-T3 |
| titleOfInvention | ERYTHROMYCIN DERIVATIVES LINKED IN POSITIONS 6 AND 11. |
| abstract | A compound selected from the group consisting of: ** FORMULA ** where m is 0, 1, 2, 3, 4, 5, 6 or 7; n is 0, 1, 2, 3, or 4; Rp is independently hydrogen or a hydroxy protecting group in each case; A is absent or selected from the group consisting of (1) -O- and (2) -N (R1) -, where R1 is hydrogen or C1-C6 alkyl optionally substituted with aryl or heteroaryl; B is absent or is selected from the group consisting of (1) - (CH2) q-, where q is 0, 1, 2, 3, 4, 5 or 6; (2) -C (O) - (CH2) q-, (3) -C (O) - (CH2) q (4) -C (O) -NR1- (CH2) q-, where R1 is, as defined above, and (5) -N = CH- (CH2) q-; (6) -CH (OH) - (CH2) q-, and (7) -CH (OH) -CH (OH) - (CH2) q-; D is absent or selected from the group consisting of (1) alkenylene, (2) arylene, (3) substituted arylene, (4) heteroarylene, (5) substituted heteroarylene, (6) alkenylene-arylene, (7) arylene- arylene, (8) substituted arylene-arylene, (9) heteroarylene-arylene, (10) heteroarylene-substituted arylene, (11) alkenylene-heteroarylene, (12) arylene-heteroarylene, (13) substituted arylene-heteroarylene, (14) heteroarylene-heteroarylene, and (15) substituted heteroarylene-heteroarylene; E is absent or selected from the group consisting of (1) (CH2) r-CH = CH-, (2) (CH2) r-O-, where r is 0, 1, 2, 3 or 4; (3) (CH2) r-NR1-CH2-CH (OH) -, where R1 is, as defined above, (4) (CH2) rC (O) -O-, (5) (CH2) rN ( R1) -, (6) (CH2) rOC (O) -, (7) (CH2) rC (O) -N (R1) -, and (8) (CH2) rN (R1) -C (O) - , with the restrictions that the sum of m + q cannot be 0, that the sum of m + n + q + r is an integer from 2 to 7, that when the two remains A and B are absent then m cannot be 0, that when E is -CH = CH- and all the remains A, B and D are absent then m cannot be O and that B can be -N = CH- (CH2) q- only when A is absent and m is 0. |
| priorityDate | 1997-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 270.